The present invention provides a method for the treatment of immune mediatedor immune related diseases or disorders, infectious diseases, metabolicdisorders and cancer in mammalian subjects. This method comprises theadministration of a naturally occurring, mammalian intermediary metabolite orT cell receptor ligand, preferably a glucosylceramide, to a mammalian subject.In a preferred embodiment, such mammalian subjects are human beings.
